1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd.

KMTS
Kestra Medical Technologies, Ltd.US flagNASDAQ Global Select
18.82
USD
- -
- -
1.10BMarket Cap

Total Valuation

Kestra Medical Technologies, Ltd. carries a market capitalization of 1.10B, placing it among publicly traded companies globally. Its enterprise value stands at 884.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.10B
Enterprise Value884.58M

Share Statistics

Kestra Medical Technologies, Ltd. currently has 58.35M shares outstanding.

Shares Outstanding58.35M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 13.49, and the price-to-book ratio stands at -2.04.

PE RatioN/A
PS Ratio13.49
PB Ratio-2.04
P/TBV Ratio3.92
P/FCF Ratio-21.36
P/OCF Ratio-13.03

Enterprise Valuation

EV / Sales10.57
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Kestra Medical Technologies, Ltd. maintains a current ratio of 7.32, meaning it holds 7.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.16, indicating elevated leverage, while an interest coverage ratio of -18.15 demonstrates limited ability to service its debt obligations.

Current Ratio7.32
Quick Ratio7.08
Debt / Equity16.16
Debt / EBITDA-0.34
Interest Coverage-18.15

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-59.44
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover6.69

Taxes

Income Tax204,000.00
Effective Tax RateN/A

Stock Price Statistics

Kestra Medical Technologies, Ltd.'s stock has declined approximately -4.90147% over the past 52 weeks. The 50-day moving average sits at 20.71, while the 200-day moving average is 23.12.

Beta (5Y)N/A
52-Week Price Change-4.90147%
50-Day Moving Average20.71
200-Day Moving Average23.12
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Kestra Medical Technologies, Ltd. generated 83.72M in revenue and converted that into -144.83M in net income, yielding earnings per share of -3.14. EBITDA reached -135.39M, while operating income came in at -143.61M.

Revenue83.72M
Gross Profit40.81M
Operating Income-143.61M
Pretax Income-143.68M
Net Income-144.83M
EBITDA-135.39M
EBIT-143.61M
Earnings Per Share (EPS)-3.14

Balance Sheet

Kestra Medical Technologies, Ltd. holds 291.32M in cash and equivalents against 46.55M in total debt, resulting in a net debt position of -249.06M. Total book value stands at -554.68M, with working capital of 271.13M providing operational flexibility.

Cash & Cash Equivalents291.32M
Total Debt46.55M
Net Debt-249.06M
Equity (Book Value)-554.68M
Book Value Per Share-12.12
Working Capital271.13M

Cash Flow

Kestra Medical Technologies, Ltd. produced -86.68M in operating cash flow over the past twelve months. After subtracting -33.80M in capital expenditures, free cash flow totaled -120.48M - equivalent to -2.63 per share.

Operating Cash Flow-86.68M
Capital Expenditures-33.80M
Free Cash Flow-120.48M
FCF Per Share-2.63

Margins

Kestra Medical Technologies, Ltd. operates with a gross margin of 48.75, reflecting its pricing power and cost economics. The operating margin of -171.53 and net profit margin of -172.99 provide insight into operational efficiency.

Gross Margin48.75
Operating Margin-171.53
Pretax Margin-171.62
Profit Margin-172.99
EBITDA Margin-161.72

Dividends & Yields

The company's payout ratio of 2.21 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.00
Dividend YieldN/A
Payout Ratio2.21
Shareholder Yield-32.05
FCF Yield-4.68

Scores

Kestra Medical Technologies, Ltd. posts an Altman Z-Score of 4.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.98